⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AQST News
Aquestive Therapeutics, Inc. Common Stock
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST
globenewswire.com
AQST
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST
globenewswire.com
AQST
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Misrepresented Anaphylm's FDA Approval Prospects: Levi & Korsinsky
globenewswire.com
AQST
AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026
prnewswire.com
AQST
Did You Lose Money Investing in Aquestive Therapeutics, Inc.? Robbins LLP Urges Investors With Significant Losses to Contact The Firm For Information About Their Rights Against AQST
accessnewswire.com
AQST
Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
AQST
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AQST
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
Pomerantz LLP Alerts Shareholders to Investor Suit Against Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST